Ragoowansi R, Cornes P G, Glees J P, Powell B W, Moss A L
Department of Plastic and Reconstructive Surgery, St George's Hospital, London, UK.
Br J Plast Surg. 2001 Sep;54(6):504-8. doi: 10.1054/bjps.2001.3656.
There is no universally agreed policy for treating keloid scars of the ear lobe following piercing. We treated 35 patients (34 women) for high-risk ear-lobe keloids; the average age was 24 years (range: 16-44 years). All had failed to respond to prior treatment with massage and silicone, and corticosteroid injection. The keloids were excised extralesionally and the defects were closed with interrupted prolene sutures. The operative scar was covered with topical 2% lignocaine-0.25% chlorhexidine sterile lubricant gel under a transparent adhesive dressing. Adjuvant postoperative radiotherapy of 10 Gy, applied as 100 kV photons (4 mm high-voltage therapy (HVT) Al), was given within 24 h of surgery. All keloid scars were controlled at 4 weeks' follow-up. At 1 year, three out of 34 cases followed up had relapsed (probability of control: 91.2%). At 5 years, a further four out of the remaining 31 patients had relapsed (cumulative probability of control at 5 years: 79.4%). There were no cases of serious toxicity.
对于耳垂穿孔后瘢痕疙瘩的治疗,目前尚无普遍认可的政策。我们治疗了35例(34名女性)高危耳垂瘢痕疙瘩患者;平均年龄为24岁(范围:16 - 44岁)。所有患者先前接受按摩、硅胶及皮质类固醇注射治疗均无效。瘢痕疙瘩在病变外切除,缺损用间断普理灵缝线缝合。手术切口用2%利多卡因 - 0.25%氯己定无菌润滑凝胶覆盖,再用透明粘性敷料包扎。术后辅助放疗10 Gy,采用100 kV光子(4 mm高压治疗(HVT)铝),在术后24小时内进行。所有瘢痕疙瘩在4周随访时得到控制。1年时,34例随访患者中有3例复发(控制概率:91.2%)。5年时,其余31例患者中又有4例复发(5年时控制的累积概率:79.4%)。无严重毒性病例。